Trial intelligence / Profile preview

High-Dose vs Standard-Dose Amoxicillin/Clavulanate for Acute Sinusitis

NCT03431337Phase 4Terminated

Start
Feb 2018
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amoxicillin in acute bacterial sinusitis (ABS). Started Feb 2018; status: terminated.

02

Drugs

amoxicillin
03

Conditions

acute bacterial sinusitis (ABS)

Beyond the preview

Go deeper on NCT03431337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03431337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call